Next Article in Journal
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis
Previous Article in Journal
68Ga-DOTATOC-PET/MRI—A Secure One-Stop Shop Imaging Tool for Robotic Radiosurgery Treatment Planning in Patients with Optic Nerve Sheath Meningioma
Previous Article in Special Issue
Cold-Shock Domains—Abundance, Structure, Properties, and Nucleic-Acid Binding
Review

Novel Insights into YB-1 Signaling and Cell Death Decisions

1
Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University, 39120 Magdeburg, Germany
2
Department of Molecular Immunology, ZKF2, Ruhr-University Bochum, 44801 Bochum, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editors: Mahmoud Toulany and Annette Lasham
Cancers 2021, 13(13), 3306; https://doi.org/10.3390/cancers13133306
Received: 1 June 2021 / Revised: 25 June 2021 / Accepted: 29 June 2021 / Published: 1 July 2021
(This article belongs to the Special Issue Close links between Cold Shock Proteins and Cancer)
Signals that determine cell survival or death are essential for maintaining tissue homeostasis. Cell death promotes the removal of unwanted cells; however, a failure of cells to die or cells dying when they should not can exacerbate inflammation, and the former is a causative factor in cancerous diseases. YB-1 plays critical roles in cell proliferation and differentiation, stress responses, and tumorigenesis. In this review, we have summarized recent insights into the role of YB-1 in signaling cell survival and apoptosis.
YB-1 belongs to the evolutionarily conserved cold-shock domain protein family of RNA binding proteins. YB-1 is a well-known transcriptional and translational regulator, involved in cell cycle progression, DNA damage repair, RNA splicing, and stress responses. Cell stress occurs in many forms, e.g., radiation, hyperthermia, lipopolysaccharide (LPS) produced by bacteria, and interferons released in response to viral infection. Binding of the latter factors to their receptors induces kinase activation, which results in the phosphorylation of YB-1. These pathways also activate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), a well-known transcription factor. NF-κB is upregulated following cellular stress and orchestrates inflammatory responses, cell proliferation, and differentiation. Inflammation and cancer are known to share common mechanisms, such as the recruitment of infiltrating macrophages and development of an inflammatory microenvironment. Several recent papers elaborate the role of YB-1 in activating NF-κB and signaling cell survival. Depleting YB-1 may tip the balance from survival to enhanced apoptosis. Therefore, strategies that target YB-1 might be a viable therapeutic option to treat inflammatory diseases and improve tumor therapy. View Full-Text
Keywords: YB-1; TNF; NF-κB; apoptosis YB-1; TNF; NF-κB; apoptosis
Show Figures

Graphical abstract

MDPI and ACS Style

Shah, A.; Lindquist, J.A.; Rosendahl, L.; Schmitz, I.; Mertens, P.R. Novel Insights into YB-1 Signaling and Cell Death Decisions. Cancers 2021, 13, 3306. https://doi.org/10.3390/cancers13133306

AMA Style

Shah A, Lindquist JA, Rosendahl L, Schmitz I, Mertens PR. Novel Insights into YB-1 Signaling and Cell Death Decisions. Cancers. 2021; 13(13):3306. https://doi.org/10.3390/cancers13133306

Chicago/Turabian Style

Shah, Aneri, Jonathan A. Lindquist, Lars Rosendahl, Ingo Schmitz, and Peter R. Mertens. 2021. "Novel Insights into YB-1 Signaling and Cell Death Decisions" Cancers 13, no. 13: 3306. https://doi.org/10.3390/cancers13133306

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop